Fielmann Group supports medical study by University Medical Center Hamburg-Eppendorf (UKE) on innovative eyecare
|
Fielmann Group supports medical study by University Medical Center Hamburg-Eppendorf (UKE) on innovative eyecare
Together with Ocumeda, a leading tele-ophthalmological platform in Europe, Fielmann Group introduced the Eye Health Checkup, an innovative medical offering that makes eye health affordable and accessible for everyone. The service has been rolled out since 2024 and is currently being offered in all major Fielmann stores in Austria, Germany and Switzerland. 300,000 customers have already used the service and in 20% of the cases, conspicuous findings led to a recommendation for further checkups and treatments at local ophthalmologists and clinics. This medical service is now being scientifically examined by the University Medical Center Hamburg-Eppendorf (UKE), supported by Fielmann with €600,000. The scientific study is led by the Director of the hospital’s Ophthalmology Department, Prof. Dr. Martin Spitzer. Its goal is to scientifically evaluate the tele-ophthalmological offering, comparing its results to those of a medical eye exam carried out in person by an ophthalmologist at the university clinic. About the Eye Health Service at Fielmann About the medical study – free ophthalmologist consultations for Fielmann customers „Having your eye health checked regularly is important. More than 300,000 customers have already chosen the most convenient way – our medical Eye Health Checkup. By asking one of the most renowned medical research institutions in Europe to scientifically evaluate this innovative service, we underscore Fielmann’s commitment to delivering quality medical services in close collaboration with our partners in ophthalmology. This study marks another important milestone in our Vision 2035 growth strategy, which aims to make primary eyecare accessible and affordable. This way we pursue our purpose – to help everyone hear and see the beauty in the world”, says Marc Fielmann, CEO of the Fielmann Group. Why primary eyecare is important The following Fielmann stores are offering the Eye Health Checkup and are participating in the scientific study:
Hamburg, Germany ˗ November 4, 2025 Fielmann Group AG The Management Board ABOUT FIELMANN GROUP AG ABOUT OCUMEDA AG ABOUT UKE CONTACT
End of Media Release Issuer: Fielmann Group AG Key word(s): Special Topics
04.11.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Fielmann Group AG |
| Fuhlsbuettler Straße 399 | |
| 22309 Hamburg | |
| Germany | |
| Phone: | +49 40 270 76-0 |
| Fax: | +49 40 270 76-390 |
| Internet: | www.fielmann-group.com |
| ISIN: | DE0005772206 |
| WKN: | 577220 |
| Indices: | MDAX |
| Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange |
| EQS News ID: | 2222812 |
| End of News | EQS Media |
|
|
2222812 04.11.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 1.520,75 | 1.428,93 | 1.678,15 | 1.759,30 | 1.969,08 | 2.264,12 | 2.490,00 | |
| EBITDA1,2 | 384,70 | 336,70 | 396,13 | 339,85 | 410,00 | 470,64 | 560,00 | |
| EBITDA-Margin3 | 25,30 | 23,56 | 23,61 | 19,32 | 20,82 | 20,79 | 22,49 | |
| EBIT1,4 | 253,70 | 176,26 | 308,88 | 160,47 | 213,81 | 255,62 | 340,00 | |
| EBIT-Margin5 | 16,68 | 12,34 | 18,41 | 9,12 | 10,86 | 11,29 | 13,66 | |
| Net Profit (Loss)1 | 177,29 | 120,81 | 144,58 | 109,95 | 130,64 | 154,20 | 209,00 | |
| Net-Margin6 | 11,66 | 8,46 | 8,62 | 6,25 | 6,64 | 6,81 | 8,39 | |
| Cashflow1,7 | 301,75 | 278,47 | 346,69 | 268,09 | 282,79 | 410,09 | 443,00 | |
| Earnings per share8 | 2,05 | 1,39 | 1,63 | 1,24 | 1,52 | 1,95 | 2,45 | |
| Dividend per share8 | 0,00 | 1,20 | 1,50 | 0,75 | 1,00 | 1,15 | 1,30 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PricewaterhouseCoopers
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Fielmann | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 577220 | DE0005772206 | AG | 3.603,60 Mio € | 15.09.1994 | Kaufen | 9F5GH2JH+5V |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 16,56 | 31,51 | 0,53 | 26,53 | 4,49 | 8,79 | 1,59 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 1,00 | 1,15 | 1,30 | 3,03% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 10.07.2025 | 08.05.2025 | 10.07.2025 | 06.11.2025 | 30.04.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -10,87% | -14,95% | +3,62% | +7,79% | +654,22% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.